BioSpace News Archive

CRH Medical Corporation (the “Company”) (TSX: CRH) (NYSE MKT: CRHM), announces that Dr. Anthony Holler has advised the Company that he will resign as a member and Chair of the Board of Directors of the Company effective immediately in order to focus on other business matters.

Zymergen Announces Acquisition of enEvolv, Accelerating Ability to Deliver High-Value Products to Market

Publicly available resource monitors development of therapies to treat and prevent disease

GE Healthcare President & CEO Kieran Murphy issued the following statement around efforts to address the coronavirus

BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing artificial intelligence to identify improved therapies in neuroscience and immuno-oncology, announced that more than one-third of the patients in the Phase 3 SERENITY trials have been enrolled and treated.

BiondVax Pharmaceuticals Ltd. issued an update regarding the impact of the COVID-19 pandemic on the ongoing pivotal, clinical efficacy, Phase 3 trial in Europe of the Company’s M-001 universal influenza vaccine candidate..

Marinus Pharmaceuticals, Inc. today announced the appointment of Sasha Damouni Ellis as Vice President, Investor Relations and Corporate Communications, reporting to Scott Braunstein, M.D., Chief Executive Officer of Marinus. In this role, Ms. Damouni Ellis will lead strategic investor relations and communication

Optune Lua, formerly known as NovoTTF-100L, is the first FDA-approved treatment for malignant pleural mesothelioma in over 15 years

By using mobile-first technology, one hospital connects resources and clinicians in real-time for consultation, collaboration, and human connection during the COVID-19 pandemic

Kidney patients are among the high-risk groups of people with chronic medical conditions who may experience more serious COVID-19 illness . While kidney patients are being encouraged to stay home and avoid crowds as much as possible during the outbreak, those treated with in-center hemodialysis must also continue their scheduled dialysi